Equity Analysis /
United States of America

US : Amneal Pharmaceuticals Inc. - AMRX | Expands Neurology Presence With Baclofen Franchise, Adds Institutional Support for Biologics

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    5 January 2022
    Published by